Search Result "quilizumab"


Quilizumab is an Afucosylated Humanized Anti-M1 Prime Therapeutic Antibody

Journal: Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)
Volume: 1 Issue: 1 Year: 2014 Page: 24-31
Author(s): Hans D. Brightbill,Yuwen L. Lin,Zhonghua Lin,Martha Tan,Y. Gloria Meng,Mercedesz Balazs,Shan Chung,Lawren C. Wu

Review Article open access plus

An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases

Journal: Current Respiratory Medicine Reviews
Volume: 13 Issue: 1 Year: 2017 Page: 22-29
Author(s): Amelia Licari,Riccardo Castagnoli,Elisa Panfili,Alessia Marseglia,Ilaria Brambilla,Gian Luigi Marseglia

Therapeutic Targeting of Type 2 Inflammation for the Treatment of Severe Asthma

Journal: Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)
Volume: 1 Issue: 1 Year: 2014 Page: 2-10
Author(s): Lawren C. Wu,Joseph R. Arron,Jeffrey M. Harris,John G. Matthews,Karin Rosen

Review Article

Omalizumab in the Therapy of Pediatric Asthma

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 12 Issue: 2 Year: 2018 Page: 103-109
Author(s): Dimitri Poddighe,Ilaria Brambilla,Amelia , Licari,Gian Luigi Marseglia

Review Article

Novel Biological Therapies in Severe Asthma: Targeting the Right Trait

Journal: Current Medicinal Chemistry
Volume: 26 Issue: 1 Year: 2019 Page: 2801-2822
Author(s): Gilda Varricchi,Giancarlo Marone,Giuseppe Spadaro,Michele Russo,Francescopaolo Granata,Arturo Genovese,Gianni Marone

Engineering Approaches to Develop the Next Generation of Antibodies to Respiratory Targets

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 12 Issue: 2 Year: 2013 Page: 99-108
Author(s): Katherine A. Vousden, Deborah L. Clarke, David C. Lowe

Results 1 - 1 of 6

Filter Result

Volume Year
Ads
© 2022 Bentham Science Publishers | Privacy Policy